openPR Logo

Press Releases from Harver Group (8 total)

Banking Sector Roundup July 30th 2013 – A Difficult Day For A Number Of Banks

JP Morgan, Barclays, and Deutsche Bank are all having legal troubles. A JP Morgan division is accused of manipulating electricity markets, Barclays of not disclosing fees paid, and Deutsche Bank has a number of charges levied against it. Jul. 31, 2013 - CHUO-KU, Japan -- Major banks across the global are having legal and financial difficulties including; JP Morgan, Barclays, and Deutsche Bank. A division of JP Morgan Chase & Co.

Harver Group Appoints Senior Analyst Steven Vaughan

Experienced Trader to replace Senior Analyst at Harver Group. Jul. 18, 2013 - CHUO-KU, Japan -- Today Director and Co-founder at Harver Group Koji Masuto, announced that Steven Vaughan will be taking over as Senior Analyst. Mr. Vaughan will be replacing Michael Jones, who is retiring at the end of the year after 7 years of loyal service to Harver Group. “Michael Jones has performed an indispensable role during what has

European Markets Overview – 29th July 2013

Analysts at equity researcher Harver Group report advertising firms were some of the biggest gainers on Monday while Barclays and Ryan air share prices declined significantly. Jul. 30, 2013 - CHUO-KU, Japan -- The Stoxx Europe 600 index climbed half a point to 300.2, after a 0.2% dip on Friday. We expect the markets to remain fairly stagnant until later this week, as investor monitor meetings of The European Central Bank,

Harver Group Market Watch: Asia 26-07-13

The Asian markets were largely stagnate Thursday despite stimulus measures being unveiled in Beijing. Mining and Metal stocks were down as were major Japanese camera manufactures. The Chinese railway sector posted small gains. Jul. 26, 2013 - CHUO-KU, Japan -- Asian Markets faltered slightly Thursday; South Korea´s Kospi stock average dropped 0.1%, Japan´s Nikkei lost 1.1%, while Australia´s S&P/ASX 200 had a negligible gain. The situation in China and Hong Kong

Harver Group Releases IPO Forecast For July 2013

Tokyo based equity researcher Harver Group has released its predictions for the top performing IPOs of July 2013. Jul. 17, 2013 - CHUO-KU, Japan -- Peter Anderson, Senior Vice President of Mergers and Acquisitions at boutique equity research house Harver Group in Tokyo today approved the release of the company’s IPO forecast, written by the company’s head of investment analysis Mr. Nathan Marx and Director of Private Equity Mr. Stephen James.

Harver Group Targets BioTech Bull

Synta Pharmaceuticals has a bullish outlook for Q3-Q4; insider buying indicates the company will be releasing positive research results and see a gain in returns. Jul. 24, 2013 - CHUO-KU, Japan -- Due to the huge increase in staff and board members buying stock in Synta Pharmaceuticals, and the successful trials of Synta Pharmaceuticals latest cancer drug Ganetespib, Pharmaceutical Analysts at Harver Group are now strongly recommending the stock as a

Harver Group Investing Heavily In Potential Cancer Cure

Harvard Bioscience Inc. and its subsidiary Harvard Apparatus Regenerative Technology have high profit potential, stemming from ground breaking technology and a buy out of the parent company. Jul. 22, 2013 - CHUO-KU, Japan -- Harvard Bioscience Inc. (HBIO) has received little attention for their research from the medical establishment or from educational institutions. While posting consistent growth and a strong customer base, shareholders have not seen much profit to date

Lifetime Achievement Award Given to Martin Owen At Harver Group

At Harver Group´s annual awards dinner last weekend, Senior Analyst Mr. Martin Owen received the Company’s highest honor; The Lifetime Achievement Award. Jul. 11, 2013 - CHUO-KU, Japan -- "We here at Harver Group are tremendously proud of Martin Owen, he joined Harver Group at its inception 10 years ago and since then, he has continually been a beacon of integrity and hard work. He has always put the clients first

Go To Page:   1 2 3 4 5 6 7 8 9 10